Psoriasis: Recognition and Management Strategies

Area of Science:

• Dermatology
• Immunology
• Systemic Inflammatory Diseases

Background:

• Psoriasis is an immune-mediated skin and systemic disorder affecting 3.2% of the U.S. population.
• It is linked to various comorbidities, including cardiovascular disease, obesity, and diabetes.
• Psoriasis manifests in several forms, with plaque psoriasis being the most common.

Purpose of the Study:

• To provide a comprehensive overview of psoriasis, encompassing its epidemiology, pathophysiology, clinical presentation, and management.
• To highlight the importance of a multidisciplinary approach in managing psoriasis and its associated conditions.

Main Methods:

• Clinical diagnosis based on characteristic skin plaques and patient history.
• Assessment of disease severity using tools like the Psoriasis Area and Severity Index (PASI).
• Treatment strategies categorized by disease severity (mild-to-moderate vs. moderate-to-severe) and form.

Main Results:

• Psoriasis affects 3.2% of the U.S. population, with plaque psoriasis being the most prevalent form.
• Treatment options range from topical corticosteroids and vitamin D analogues for mild cases to systemic agents and phototherapy for severe cases.
• Lifestyle modifications such as weight management, smoking cessation, and stress reduction are crucial for disease management.

Conclusions:

• Psoriasis requires a comprehensive management strategy, including medical treatment and lifestyle adjustments.
• Special populations, including children and pregnant or breastfeeding individuals, require tailored treatment considerations.
• Effective management improves patient outcomes and quality of life, emphasizing the need for ongoing monitoring and personalized care.